| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K66453893 |
| PharmacoGx | BRD-K66453893 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WFDC13 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.005 |
| mRNA | TTK | CTRPv2 | pan-cancer | AAC | 0.086 | 0.005 |
| mRNA | PCDHGA10 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | RYR2 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.005 |
| mRNA | PSAT1 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.005 |
| mRNA | MESDC2 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.005 |
| mRNA | TIMM13 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.005 |
| mRNA | DAB1 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | BHLHE22 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.005 |
| mRNA | MLPH | CTRPv2 | pan-cancer | AAC | -0.096 | 0.005 |
